Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

(2010) Andreas A Schnitzbauer et al.   BMC CANCER

Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma

(2010) Marco Vivarelli et al.   TRANSPLANTATION

Clinical Insights for Cancer Outcomes in Renal Transplant Patients

(2010) J. Alberú   TRANSPLANTATION PROCEEDINGS

Systematic Review and Meta-Analysis of the Role of Defunctioning Stoma in Low Rectal Cancer Surgery

(2009) Norbert Hüser et al.   ANNALS OF SURGERY

Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients

(2009) Christin C. Rogers et al.   CLINICAL TRANSPLANTATION

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

(2009) Christian Toso et al.   HEPATOLOGY

Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

(2009) Srinath Chinnakotla et al.   LIVER TRANSPLANTATION

Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors

(2008) Marco Vivarelli et al.   ANNALS OF SURGERY

Recurrence of Hepatocellular Carcinoma Following Liver Transplantation

(2008) Michael A. Zimmerman   ARCHIVES OF SURGERY

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2008) Michael A. Zimmerman et al.   LIVER TRANSPLANTATION

Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria

(2008) J. Zhou et al.   TRANSPLANTATION PROCEEDINGS